Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Cell Culture Market: USD 13.00 billion Growth from 2020 to 2025 | Established Vendors Acquiring Smaller Players to Enhance Global Reach | Technavio


NEW YORK , June 14, 2022 /PRNewswire/ -- Cell culture is a process of growing cells under controlled or in-vitro conditions. The cell culture process is used to study basic cell biology, biochemistry, and the interaction between cells and disease-causing agents such as bacteria and viruses.

Technavio estimates that the cell culture market size will grow by USD 13.00 billion from 2020 to 2025. The growth momentum of the market will accelerate at a CAGR of 10.67% during the forecast period.

Get a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format

Porter's Five Forces Analysis

The global cell culture market is highly competitive owing to the presence of several small and large players. The market is concentrated, and vendors are differentiating themselves by offering value-added services and competitive pricing. Hence, the threat of rivalry is expected to be high during the forecast period.

The Report offers information on all the Porter's Five Forces. Buy Now to gain insights that will help you improve your business.

Vendor Landscape

The global cell culture equipment market is dominated by a few well-established manufacturers. Major players are focusing on developing innovative products and are constantly increasing their R&D investments. The established vendors have started acquiring smaller and regional players to enhance their global reach. The market will also witness the entry of several new players, which will intensify the level of competition. Some of the key vendors operating in the market include Merck KGaA, Bio-Techne Corp., Corning Inc., Danaher Corp., and General Electric Co.

The report provides a full list of key vendors, their strategies, and the latest developments. Request a PDF Sample Now 

Market Segmentation

The cell culture market has been segmented by product into consumables and equipment. The consumables segment will have significant market share growth during the forecast period. This is due to factors such as high availability, vast applicability, repeated usage, and low price.

By geography, the market has been segmented into North America, Europe, Asia, and ROW. North America will have the highest market growth during the forecast period. The growth is attributed to factors such as the presence of major companies such as Becton, Dickinson and Co. (BD,) Corning, Danaher, and Thermo Fisher Scientific, which are investing in new manufacturing facilities.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Key Drivers and Trends

The increase in infectious diseases will drive the growth of the cell culture market during the forecast period. There have been several cases of viral infections such as Ebola, severe acute respiratory syndrome (SARS), swine flu, Zika, Lassa fever, and COVID-19. The preference for cell-based vaccines has increased to treat such diseases.

The rising demand for monoclonal antibodies is a trend in the market. There is a high demand for antibiotic treatment with the growing prevalence of chronic diseases. Large manufacturers have built large-scale manufacturing plants that contain multiple cell culture bioreactors for antibody production, which is fueling the global cell culture market.

Apart from the rising demand for monoclonal antibodies, many other trends are also shaping the future of the market. View PDF Sample Report to learn about these trends

Similar Reports

Cellular Health Screening Market by Channel and Geography - Forecast and Analysis 2022-2026

Hairy Cell Leukemia Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026

Cell Culture Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 10.67%

Market growth 2021-2025

USD 13.00 billion

Market structure

Concentrated

YoY growth (%)

9.95

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 37%

Key consumer countries

US, Germany, France, Japan, and UK

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agilent Technologies Inc., Becton Dickinson and Co., Bio-Techne Corp., Corning Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Lonza Group Ltd., Merck KGaA, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents

1 Executive Summary

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 11:18
Inside information: Alan Donze has been appointed as Bioretec's new CEO
Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec as of today, 20 May 2024. He will start in this position immediately. With a distinguished career spanning the banking and medical device industries, Mr. Donze...

at 11:16
POSITIVE DATA FROM IN VIVO STUDY SHOWS SIGNIFICANT ANTIMICROBIAL ACTIVITY OF OCMtm AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND PSEUDOMONAS AERUGINOSA (PA) IN PORCINE WOUND MODEL
Omeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, recently presented in vivo data showing that OCMtm wound matrix alone...

at 11:10
BayCare Expands Graduate Medical Education to Include Surgery Residency Program
As part of its plan to bring more doctors to West Central Florida, the region's top health care system today announced that it will soon launch BayCare Health System's first surgery residency program. The Accreditation Council for Graduate Medical...

at 11:01
Life Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive Report by Meticulous Research®
According to a new market research report titled, 'Life Science Equipment Market Size, Share, Forecast, & Trends Analysis By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry,...

at 11:00
HealthWell Foundation Announces Sponsorship of Family Reach Clinical Trial Access Fund
The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans, as part of its ongoing commitment to The White House Cancer Moonshot, is honored to announce its sponsorship...

at 11:00
Balance Point Announces its Investment in SG Homecare
Balance Point Capital Advisors, LLC ("Balance Point"), in conjunction with its affiliated funds, Balance Point Capital Partners V, L.P. and Balance Point Capital Partners VI, L.P., is pleased to announce its investment in SG Homecare ("SG", or the...

More news about Health...


News published on and distributed by: